The autotransfusion process involves the reinfusion of the patient’s blood. Blood is collected from the peritoneal cavity or thorax region. The process can be carried out before surgery or during and after the surgery using the autotransfusion system. Medical procedures, like joint replacement, spinal surgeries, and cardiac, among others, require autotransfusion. It helps to reduce the risk of infection, and also it eliminates the problems and complications associated with the banking and administration of homologous donor blood. It helps to prevent the transmission of transfusion-related blood-borne diseases in patients.
Medtronic and Fresenius SE & Co. KGaA – Notable Market Players in Autotransfusion Devices Market
The autotransfusion devices market is majorly comprised of top players such as BD, Braile Biomedica, Fresenius SE & Co. KGaA, Haemonetics Corporation, LivaNova PLC, Medtronic, Redax S.p.A., SARSTEDT AG and Co. KG, Teleflex Incorporated and Zimmer Biomet among others.
The companies listed above are implementing various strategies that have resulted in the growth of the company and in turn, have brought about various changes in the global autotransfusion devices market. Additionally, the companies have adopted several inorganic and organic strategies for accelerating their growth and improving their market position.
Below is the list of the growth strategies done by the players operating in the autotransfusion devices market:
| Year | News |
| Aug-2020 | Teleflex Incorporated initiated Class 2 Device Recall for its autotransfusion device PleurEvac, as directed by U.S Food and Drug Administration (USFDA). The product was recalled due to Potential for sterile packaging to be compromised. |
| Jan-2020 | Haemonetics Corporation initiated Class 2 device recall for its autotransfussion system Cell Saver Elite + as directed by U.S Food and Drug Administration (USFDA). The product was recalled due to the Potential to develop leaks at the inner core of Cell Saver 5/5+ and Cell Saver Elite/Elite +125ml and 225ml bowl sets that could result in fluid being trapped inside the bowl core, causing a long empty device error message with the possibility of incomplete washing. |
| Dec-2020 | Zimmer Biomet acquired A&E Medical Corporation for USD 150 million in cash at closing and USD 100 million in cash payable in 2021. As per the terms of the acquisition, Zimmer Biomet acquired A&E Medical and its complete portfolio of sternal closure devices – including sternal sutures, cable systems, and rigid fixation. |
| Apr-2020 | SARSTEDT AG and Co. KG acquired 80% of the shares in Timedico A/S and secured a right to acquire additional 20% in the near future. The acquisition has helped the company to leverage its value proposition to company’s global customers. |
